Kidanewold Aschalew, Woldu Berhanu, Getie Asmare, Enawgaw Bamlaku
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.
Department of Hematology & Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Curr Med Res Opin. 2022 Mar;38(3):393-400. doi: 10.1080/03007995.2021.2012965. Epub 2021 Dec 21.
Anemia is an adverse outcome and common complication in chronic kidney disease patients. This is usually associated with iron deficiency, inflammation and blood loss. However, little is known about the prevalence of anemia and its predictors among chronic kidney disease patients in Southern Ethiopia. This study aimed to determine anemia and its predictors among adult non-dialysis chronic kidney disease patients in Southern Ethiopia.
A cross-sectional study was conducted on 384 chronic kidney disease patients from February to April 2019. Socio-demographic and clinical data were collected using questionnaires and medical records. Adjusted hemoglobin was taken to define anemia using the level of Hgb <13 mg/dL for males and <12 mg/dL for females; and blood films and serum ferritin were done for anemic participants. SPSS version 25.0 was used for data analysis. Frequency distribution tables and graphs were used to describe descriptive statistics. A bivariate logistic regression model was used to determine the predictors; <.05 was considered statistically significant.
Overall prevalence of anemia was 44.0% (95% CI: 39.0%, 48.9%); of which 7.1%, 62.1% and 30.8% of anemic patients had mild, moderate and severe anemia, respectively. The prevalence of anemia increased from 20.6% in stage 2 to 100% in stage 5. Morphologically, normocytic normochromic anemia was the most predominant type. Cardiovascular disease (AOR = 2.37, 95% CI: 1.35, 4.16), diabetes mellitus (AOR = 2.77, 95% CI: 1.08, 7.14), stage 3b chronic kidney disease (AOR = 2.74, 95% CI: 1.31, 5.73) and stage 4 and 5 chronic kidney disease patients (AOR = 7.11, 95% CI: 3.22, 15.72) showed significant association with anemia.
Anemia was a severe public health problem and associated with cardiovascular disease, diabetes mellitus and stages of chronic kidney disease. Thus, early diagnosis, treatment and prevention of anemia are recommended.
贫血是慢性肾脏病患者的不良结局和常见并发症。这通常与缺铁、炎症和失血有关。然而,埃塞俄比亚南部慢性肾脏病患者中贫血的患病率及其预测因素鲜为人知。本研究旨在确定埃塞俄比亚南部成年非透析慢性肾脏病患者中的贫血情况及其预测因素。
2019年2月至4月对384例慢性肾脏病患者进行了一项横断面研究。使用问卷和病历收集社会人口统计学和临床数据。采用校正血红蛋白来定义贫血,男性血红蛋白水平<13mg/dL,女性<12mg/dL;对贫血参与者进行血涂片和血清铁蛋白检查。使用SPSS 25.0版进行数据分析。频率分布表和图表用于描述描述性统计。采用二元逻辑回归模型确定预测因素;P<0.05被认为具有统计学意义。
贫血的总体患病率为44.0%(95%CI:39.0%,48.9%);其中7.1%、62.1%和30.8%的贫血患者分别患有轻度、中度和重度贫血。贫血患病率从2期的20.6%增加到5期的100%。形态学上,正细胞正色素性贫血是最主要的类型。心血管疾病(调整后比值比[AOR]=2.37,95%CI:1.35,4.16)、糖尿病(AOR=2.77,95%CI:1.08,7.14)、3b期慢性肾脏病(AOR=2.74,95%CI:1.31,5.73)以及4期和5期慢性肾脏病患者(AOR=7.11,95%CI:3.22,15.72)与贫血显著相关。
贫血是一个严重的公共卫生问题,与心血管疾病、糖尿病和慢性肾脏病分期有关。因此,建议对贫血进行早期诊断、治疗和预防。